EZH2 and cancer: Our analyses focused on several key NMPs including SATB1/2, SAFB1/2, EZH2, SUZ12, BMI1, PCL3, RAE28, and CTCF, as these NMPs have been shown to be aberrantly expressed in cancers (Lever & Sheer, 2010).